CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting
D G Courtney, J E Moore, S D Atkinson, E Maurizi, E H A Allen, D. M. L. Leslie Pedrioli, W H I Mclean, M A Nesbit (Lead / Corresponding author), C B T Moore (Lead / Corresponding author)
Dive into the research topics of 'CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting'. Together they form a unique fingerprint.